Dashboard
Manage Tickers

PRLD


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

prelude-therapeutics-q3-eps-026-beats-036-estimate-sales-6500m-up-from-3000m-yoy
Prelude Therapeutics Q3 EPS $(0.26) Beats ...
11/12/2025 12:06:45

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of ...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
11/04/2025 21:06:29

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
11/04/2025 17:06:03

dow-dips-over-400-points-pfizer-earnings-top-estimates
Dow Dips Over 400 Points; Pfizer Earnings ...
11/04/2025 14:53:19

Core News & Articles
Market-Moving News for November 4th
11/04/2025 12:24:43

PRLD: 70% | Prelude Therapeutics Signs Agreement For Incyte To Acquire JAK2V617F JH2 Inhibitor Program In Development For Patie...

trading-halt-halt-status-updated-at-71500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:15:...
11/04/2025 12:15:07

Core News & Articles
Prelude Therapeutics Signs Agreement For I...
11/04/2025 12:07:54

Prelude Therapeutics Incorporated (NASDAQ:PRLD), a clinical-stage precision oncology company, today announced an exclusive opti...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
11/04/2025 12:05:48

trading-halt-halted-at-65500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 6:55:00 a.m. ET - ...
11/04/2025 11:55:04

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
11/03/2025 21:12:06

prelude-therapeutics-granted-us-patent--us-12448389-b2-for-brm-targeting-compounds-and-associated-methods-of-use
Prelude Therapeutics Granted U.S. Patent #...
10/21/2025 20:00:30

https://ppubs.uspto.gov/api/pdf/downloadPdf/12448389?requestToken=eyJzdWIiOiJlZWQ3ZTE2MS1kZjI1LTQyNTktODVjNy02NmE4NGMzYWM1ZDciL...

hc-wainwright--co-reiterates-buy-on-prelude-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Prel...
09/23/2025 11:08:35

HC Wainwright & Co. analyst Robert Burns reiterates Prelude Therapeutics (NASDAQ:PRLD) with a Buy and maintains $5 price...

jmp-securities-maintains-market-outperform-on-prelude-therapeutics-lowers-price-target-to-3
JMP Securities Maintains Market Outperform...
08/18/2025 14:37:02

JMP Securities analyst Reni J. Benjamin maintains Prelude Therapeutics (NASDAQ:PRLD) with a Market Outperform and lowers the...

prelude-therapeutics-q2-eps-041-beats-044-estimate-current-cash-runway-into-q2-of-2026-with-773m-in-cash-cash-equivalents-restricted-cash-and-marketable-securities
Prelude Therapeutics Q2 EPS $(0.41) Beats ...
08/14/2025 11:18:51

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/27/2025 21:06:12

prelude-therapeutics-q1-eps-042-beats-047-estimate
Prelude Therapeutics Q1 EPS $(0.42) Beats ...
05/06/2025 20:36:35

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of ...

hc-wainwright--co-reiterates-buy-on-prelude-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Prel...
05/05/2025 10:44:26

HC Wainwright & Co. analyst Robert Burns reiterates Prelude Therapeutics (NASDAQ:PRLD) with a Buy and maintains $5 price...

jmp-securities-reiterates-market-outperform-on-prelude-therapeutics-maintains-4-price-target
JMP Securities Reiterates Market Outperfor...
04/29/2025 16:36:21

JMP Securities analyst Reni Benjamin reiterates Prelude Therapeutics (NASDAQ:PRLD) with a Market Outperform and maintains $4...

hc-wainwright--co-reiterates-buy-on-prelude-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Prel...
04/08/2025 11:24:22

HC Wainwright & Co. analyst Robert Burns reiterates Prelude Therapeutics (NASDAQ:PRLD) with a Buy and maintains $5 price...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
03/28/2025 17:05:40

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION